Associated Papers
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.
André T et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2013
Select a paper to view details